About Lymphoma | Advocacy | Art | CAM | Clinical trials | Doctors - Experts - Centers | Guidelines at Diagnosis | News
Risk Factors | Side Effects | Statistics | Support | Symptoms | Tests | Treatments | Types of Lymphoma

Search Site         Guidelines at Diagnosis | About Clinical Trials            How to Help!

Patients Against Lymphoma


Menu A to Z


A | B | C | D | E |
F | G | H | I | J | K
L | M | NO | P |
Q | R | S | T | U
V | W | X | Y | Z


Getting Started
Just Diagnosed? 
Support groups
About Lymphoma
Types of Lymphoma


Acidy and cancer?

Acalabrutinib / ACP-196
(btk inhibitor) - Find trials

Adcetris - Find trials

Advisors to PAL - scientific

Advocacy perspectives

Advocacy resources

AEB071 (Sotrastaurin)  
Find trials

Alternative Medicine?
Agent Orange - compensation by VA

AGENTS targeting disease pathways

Agents, find trials by type

Alisertib - Find trials

Allogeneic Transplant


Antibiotics for Lymphoma


Antibody-drug conjugates

Antibody-radiation conjugates

Animal models

Anxiety - Living Well with Lymphoma

Apoptosis - targeting

Art of Asking Questions

Arzerra - Find trials

Ask PAL a Question

Autologous Transplant

Autoimmune disease and lymphoma

Autophagy and lymphoma

Back to menu




Belinostat - Find trials

Beta2-microglobulin - blood marker


Big Picture Questions


Biopsy / Second evaluation

Biopsies - perspective on mandating for research

Biospecimen Network

Bleeding / thrombocytopenia

Blood cells, types

Blood clots

Blood counts - low

Blood draw tips |

Blood tests

Blood test reference range  PDF

Bone density and  lymphoma

Bone marrow biopsy

Bone marrow involvement

Bone pain from growth factors

Bring to doctor list

Brochures by PAL - Decision Aids

Btk-inhibitor (ibrutinib)

Buparlisib - Find Trials

Back to menu





Cancer - what is it?

CART - Engineered T-cells
Find trials

Cardiac toxicity

Careers and cancer

Caregiver help

Centers for treatment

Chemo agents by category

Chemo Brain (side effect)

Childhood lymphoma

Children - talking to about cancer



Clinical Trials
- about our trial tools
- of Interest (PAL's Picks)
- find by class of agent

- find by agent - alphabetical

- find by type of lymphoma and treatment status

- focus on participation

- how to ask about

- reasons to consider trials

- reimbursement for participation?

- Trial Talk - experts to consult about trials

Clotting / thrombosis

CNS involvement, prophylaxis for

Compassionate Use

Complete Blood Count


Considerations at relapse

Conflict of interest in medical decisions?

Constipation, support

Conspiracy Theory?


Cost of medicine

Counterfeit drugs

Communicating our priorities to doctors

Cost of Cancer Care

CT Imaging / Risks


Cutaneous lymphoma

Back to menu




Depression is common

Diagnostic terms


Dictionary of cancer terms NCI

Diet / Exercise

Diet as Treatment?

Diffuse Large B-Cell

DLBCL: ABC or GCB type

DLBCL: double-hit

Disparities in Health Care

Doctor, patient-recommended

Doctor, reason for second opinion

 Doctor visits: Optimize / Bring list

Doctors, art of asking questions of

Donate to help

Dose - the importance of getting it right

Double-hit lymphoma


Drug costs are rising

Drug use, balancing risks and benefits - 5 questions to ask

Drug payment support

 Drugs - what is a drug?

Back to menu




Elderly, treating


Engineered T-cells

Epigenetics background

Epigenetics as basis of diet for treatment of cancer?

  Epigenetic therapy - HDAC inhibitors

Epstein Barr-Associated Lymphoma

Ethics in research

Exercise / Diet

Expanded Access to Investigational Drugs

Experts, videos

Back to menu





Family history of lymphoma?

Famous people with lymphoma


Fertility and sex

Financial Toxicity

Find and Evaluate Online Medical info

FISH test

Flu shots?

Follicular b-cell lymphoma

Food additives

Back to menu






Need to Treat

 Genes and Cancer

Glossary / NCI dictionary

Goal (intent) of therapy

Grade & Stage 


Guidance to doctors

 Guidelines at Diagnosis

Back to menu



Harmonizing Research and Treatment Goals

Hazard Ratio

Health Care Reform

Health Care Proxy

Hepatitis C and lymphoma

HIV / AIDS associated Lymphoma



(low levels of Ig antibody)

- IVIG - Mike's story


Back to menu






-low levels of


 Immune boosting as treatment?

Immune Checkpoints

Immune modulating agents

Immune suppression

Immunotherapies with links to trials

Informed consent


Insurance correspondence log PDF

 prognostic indexes

Back to menu



Justice, research principle

Back to menu



KLH - immune stimulant in vaccine


Back to menu



LDH, blood cell marker

Lirilumab - Find Trials


Leukemic phase


Lymphatic system


Lymphoma topics

Lymphoma Awareness brochure

Lymphoma Grade

Lymphoma Simplified

Lymphoma Stage 


Back to menu



Marginal Zone lymphoma | MALT | Nodal | Extranodal  Eye

MALT Support Group

Maintenance Rituxan pros and cons

Mantle Cell lymphoma (MCL)

Medical Marijuana?


Medical errors, tips to avoid

- PDF brochure

Medication & consult organizer PDF

Melanoma, risk of

Metastasis of Lymphoma?


Mind over Body? 
Does stress cause cancer?

Minimal Residual Disease (MRD)

Mission of PAL

Monitoring lymphoma

Mouse is not a Man (or Woman)

Mouth sores | Mucositis


Myths About Cancer

Back to menu




 Naltrexone (low dose)?


Natural supplements - caveats


Nausea tips

NCCN practice guidelines

Need to Treat


Night sweats


Back to menu




Obinutuzumab (Gazyva)

Odds ratio

 Off-label use of cancer drugs

 Optimize visits to doctor PDF

Back to menu





 Palliative Care

Patent law and natural compounds

Paraneoplastic Syndrome

Patient Stories

Patient-reported outcomes (PRO)

Patient Rights

Patient Tools & Decision Aids

Pathology report 

PD-1/L immune checkpoint blockade Find trials

Perspectives, advocacy

PET imaging

PI 3K kinases

PET imaging
- SUV range
- when to use

Placebo effect

Platelets, low -thrombocytopenia

Ports, for IV administration


Prognostic Factors

Programmed T-cells (CAR19)

Back to menu




Quackery - how it does harm 

Quality of Life

Questions for your doctor / PDF

Questions that can only be answered by clinical trials PDF


Back to menu



immunotherapy (RIT)



Rationale for continued study of Radioimmunotherapy

Red flags - identifying implausible medical claims


Relative Risk

Relapse - considerations

* Report Misleading Medical Promotions

Reputable, is it?  PDF

Response, Remission ... Terminology

Revlimid (lenalidomide)

Research Advocacy - resources

Research Tools

Remission / response terms

Recipe for Progress

Risk factors

Risks and Benefits, balancing


Rituxan checklist for patients on treatment

Rituxan Maintenance

- Pros and Cons of 


Back to menu



 Safety, avoiding medical errors PDF

Settings, our unique clinical circumstance

 Sex & Fertility


Side effects

Side effect, report to FDA

Sjögren Syndrome

Skin, side effects

Skin / cutaneous lymphoma


Spontaneous regression



Stem cell Transplant

Stories by patients 

Stories - Limitations

Stress causing lymphoma?

Stress, caregiver - tips

Subcutaneous Injections

Sugar restriction?

Support Groups  


Symptoms, reporting PDF

Symptoms Checklists 

Back to menu




T-cell lymphomas

T-cell therapies for lymphoma Find trials

Targeted drug - terminology

Tips for dealing with R-chemo

Tests (labs, imaging)

Test results,  rules and tips

Testicular lymphoma

 Testimonials?  PDF

Tools & Tips

Transformation to aggressive lymphoma  

Transplant (stem cell)

Travel help


Treatment decisions

Treatment decisions - Big Picture Questions

Treatment, factors that determine type & timing

Treatment goals

Treatment, preparing for PDF

Treatment, options at relapse

Treatment settings

Treatment support

Treatment types

Treatment, when to

Trial Talk - experts to consult about trials

Tumor Basics

Tumor lysis syndrome

Types of lymphoma

Back to menu





Back to menu




Vaccine, investigational

Vaccine for shingles?


Vitamin C?

Vitamin D

Back to menu




 Watch & Wait?

What's Lymphoma?

What's a Drug?

When laypersons give medical advice

Back to menu




X-rays (imaging)


Back to menu





Back to menu



 Zevalin (radioimmunotherapy)

Back to menu


AGENTS targeting disease pathways

ASH 2017 abstract search http://bit.ly/2zcZrfr 


Evidence-based information that empowers

Ask a Question  | Comment on PAL | See Comments


Patients Against Lymphoma


About PAL | Contact Us | Scientific Advisors | Partners

PAL since 2002 a 501(c)(3)
 non profit organization
Federal Tax ID # 51-0426732


The information on Lymphomation.org is not a substitute for professional medical advice or intended to replace your relationship with a physician. For all medical concerns,  you should always consult your doctor. Patients Against Lymphoma, Copyright © 2004,  All Rights Reserved. 

We ask that you be cautious about accepting online medical information - particularly testimonials. If doing your own research, scrutinize the study methods (size, type and number of studies). Ask if it's been replicated? Does it apply to your diagnosis and circumstance? ... check with your doctor, who has training and first-hand information.







New trials since SEPTEMBER 2017

What's New  

AGENTS targeting disease pathways with links to clinical trials

Broadening Eligibility Criteria to Make Clinical Trials More Representative
Joint Recommendations of the American Society of Clinical Oncology and Friends of Cancer Research

Support Groups

Trial Talk:
experts to consult for second opinions

Getting Started

Ask PAL a Question

Guidelines at Diagnosis

Patient Stories | Support Groups

Evidenced-based topics for the developed in response to patient questions and needs

Take our confidential patient/caregiver survey

and review the results in real time

Treatment support

- Back to menu -


Support Groups
 Moderation Policy



The PAL Forum message board requires a one-time registration It is not searchable on the web to help to protect your privacy

Patients Against Lymphoma Lymphomation Yahoo Support Group

MALT Support Group
Yahoo Support Group

Treatment Support tips by patients 

INDOLENT LYMPHOMA TREATMENT SURVEY: to learn about the treatments
you received, were offered,
and your role in decisions

interim report

Back to menu


 About Lymphoma

  Awareness - basic facts  about lymphoma --  public education

Brochures and tools

Grade | Stage 


Lymphatic system



What determines the type

  Where it presents

Back to menu


 Types of Lymphoma

most common type for young persons

Follicular b-cell
most common indolent type 

Diffuse Large B-Cell most common aggressive type

T-cell lymphomas

Other Types of Lymphoma

Back to menu



  Advocacy Perspectives

  Dr. Sharman's CLL & Lymphoma Blog

Weill Cornell Blog

Brian Koffman CLL blog

Participation in clinical trials!

Disclaimer:  The information on Lymphomation.org is not intended to be a substitute for 
professional medical advice or to replace your relationship with a physician.
For all medical concerns,  you should always consult your doctor. 
Patients Against Lymphoma, Copyright © 2004,  All Rights Reserved.